CXCR2 and pancreatic neoplasm: Ando et al. demonstrated that, in pancreatic cancer, by upregulating C-X-C motif chemokine 5 (CXCL5) and C-X-C-motif chemokine receptor-2 (CXCR2), cancer cells can enhance migration and invasion by inducing necroptosis [13].